About Us
Meet the people behind Variant Bio
Our team's expertise spans genetics, molecular biology, therapeutics, anthropology, and ethics. We are united in the belief that human genomics has the power to transform drug development.
![](https://variant-bio.transforms.svdcdn.com/production/default/Team-Photo-2024.jpg?w=1536&h=720&q=82&auto=format&fit=crop&dm=1720572565&s=de52d9ee883914cdc4cfaf3531164c0c)
![Headshot of Andrew Farnum](https://variant-bio.transforms.svdcdn.com/staging/default/Andrew_WebsiteHeadshot_800px.jpg?w=768&h=768&q=82&auto=format&fit=crop&dm=1688751597&s=1bd887a4c5b3afa942121518c626aeb5 768w, https://variant-bio.transforms.svdcdn.com/staging/default/Andrew_WebsiteHeadshot_800px.jpg?w=640&h=640&q=82&auto=format&fit=crop&dm=1688751597&s=6083140ccb6099c2555014f9594f6ade 640w, https://variant-bio.transforms.svdcdn.com/staging/default/Andrew_WebsiteHeadshot_800px.jpg?w=480&h=480&q=82&auto=format&fit=crop&dm=1688751597&s=bef18608fd0d460caa604d5261914712 480w)
Andrew Farnum
Chief Executive Officer
![Headshot of a staff member](https://variant-bio.transforms.svdcdn.com/staging/default/Bob-More-Website-Headshot-800px.jpg?w=768&h=768&q=82&auto=format&fit=crop&dm=1696880422&s=064f21a863156ceda0244f4f75b7dbf8 768w, https://variant-bio.transforms.svdcdn.com/staging/default/Bob-More-Website-Headshot-800px.jpg?w=640&h=640&q=82&auto=format&fit=crop&dm=1696880422&s=cd4467b95935415f35c599ab51e0c002 640w, https://variant-bio.transforms.svdcdn.com/staging/default/Bob-More-Website-Headshot-800px.jpg?w=480&h=480&q=82&auto=format&fit=crop&dm=1696880422&s=7497eb718761823b9f562a55bc02ebd6 480w)
Bob More
Managing Director, Alta Partners
![](https://variant-bio.transforms.svdcdn.com/staging/default/John-Xue-Headshot.jpeg?w=400&h=400&fm=jpeg&auto=compress&fit=crop&dm=1694537612&s=4f654aec877dfd8f7c015b6ddc19fe30 400w)
John Xue
Vice President, SoftBank
![A headshot of Josh Wolfe](https://variant-bio.transforms.svdcdn.com/staging/default/Josh-Wolfe_optimized.jpeg?w=768&h=768&q=82&auto=format&fit=crop&dm=1688752725&s=79fb97b11963c8a8ba14fecedabd3dcd 768w, https://variant-bio.transforms.svdcdn.com/staging/default/Josh-Wolfe_optimized.jpeg?w=640&h=640&q=82&auto=format&fit=crop&dm=1688752725&s=40cc96d32726e638e8cdbe32b713d930 640w, https://variant-bio.transforms.svdcdn.com/staging/default/Josh-Wolfe_optimized.jpeg?w=480&h=480&q=82&auto=format&fit=crop&dm=1688752725&s=cc012486032f2b6fe49e36214f91902d 480w)
Josh Wolfe
Co-Founder and Managing Partner, Lux Capital
![Headshot of a woman](https://variant-bio.transforms.svdcdn.com/staging/default/Julie-Sunderland_WebsiteHeadshot_800px.jpg?w=768&h=768&q=82&auto=format&fit=crop&dm=1696880314&s=542b631756daa4bab1657fa62589f1cb 768w, https://variant-bio.transforms.svdcdn.com/staging/default/Julie-Sunderland_WebsiteHeadshot_800px.jpg?w=640&h=640&q=82&auto=format&fit=crop&dm=1696880314&s=e37293a3462560352220999d727962f9 640w, https://variant-bio.transforms.svdcdn.com/staging/default/Julie-Sunderland_WebsiteHeadshot_800px.jpg?w=480&h=480&q=82&auto=format&fit=crop&dm=1696880314&s=09643d2b04c4f3bc639138912a47e167 480w)
Julie Sunderland
Co-Founder and Managing Director, Biomatics Capital
![A headshot of Rob Scott](https://variant-bio.transforms.svdcdn.com/staging/default/Rob-Scott_headshot_optimized.jpeg?w=318&h=317&fm=jpeg&auto=compress&fit=crop&dm=1688752666&s=4d28a2738c17ea9c7c5c4bd3363e10b7 318w)
Rob Scott, MD
Former CMO, Abbvie
![Headshot of Stephane Castel](https://variant-bio.transforms.svdcdn.com/staging/default/Stephane_WebsiteHeadshot_800px.jpg?w=768&h=768&q=82&auto=format&fit=crop&dm=1688753451&s=26e8c081e08d6b97a5ae54f4a1e2df40 768w, https://variant-bio.transforms.svdcdn.com/staging/default/Stephane_WebsiteHeadshot_800px.jpg?w=640&h=640&q=82&auto=format&fit=crop&dm=1688753451&s=c6e7bafc8e1e504040235530e41ca5db 640w, https://variant-bio.transforms.svdcdn.com/staging/default/Stephane_WebsiteHeadshot_800px.jpg?w=480&h=480&q=82&auto=format&fit=crop&dm=1688753451&s=a8b1ea4ad0b1ad3227d7f5bc61c80cd8 480w)
Stephane Castel, PhD
Co-Founder, Chief Technology Officer & Chief Genomics Officer